AnaptysBio Sets the Stage for an Eventful Year [The Motley Fool]
AnaptysBio, Inc. (ANAB)
Last anaptysbio, inc. earnings: 3/2 08:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.anaptysbio.com/investor-relations
Company Research
Source: The Motley Fool
Drugs in development took important steps forward, and investors can anticipate more catalysts ahead. Cory Renauer ( TMFang4apples ) May 9, 2018 at 3:48PM As a start-up biotech, AnaptysBio Inc. ( NASDAQ:ANAB ) didn't feel it necessary to conduct an earnings call after reporting first-quarter results after the bell on Tuesday. The company didn't record any revenue during the first three months of the year, but it did shore up the case for its lead assets. AnaptysBio Inc. results: The raw numbers Metric Q1 2018 Q1 2017 Year-Over-Year Change Revenue N/A N/A N/A Income from operations ($15.78 million) ($9.99 million) N/A Earnings per share ($0.63) ($0.75) N/A Data source: AnaptysBio Inc. What happened with AnaptysBio Inc. this quarter? The company reported updated data from an ongoing study
Show less
Read more
Impact Snapshot
Event Time:
ANAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANAB alerts
High impacting AnaptysBio, Inc. news events
Weekly update
A roundup of the hottest topics
ANAB
News
- Actym Therapeutics Appoints Thomas Smart as CEO [Yahoo! Finance]Yahoo! Finance
- Actym Therapeutics Appoints Thomas Smart as CEOPR Newswire
- AnaptysBio, Inc. (NASDAQ: ANAB) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.MarketBeat
- AnaptysBio, Inc. (NASDAQ: ANAB) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $47.00 price target on the stock.MarketBeat
- Why AnaptysBio Stock Zoomed Nearly 8% Higher This Week [Yahoo! Finance]Yahoo! Finance
ANAB
Earnings
- 3/11/24 - Beat
ANAB
Sec Filings
- 4/24/24 - Form ARS
- 4/24/24 - Form DEFA14A
- 4/24/24 - Form DEF
- ANAB's page on the SEC website